In this way, clinical studies demonstrated that specific antibodies against CFs (e.g., CFA/I, CS3, or CS21) or adhesins (e.g., EtpA or EatA) were protective against diarrheal disease provoked by ETEC [53]. This evidence concerns the gene TBCA and diarrheal disease.